Trial Profile
Comparison of fingolimod versus interferon beta/glatiramer acetate as second-line therapy in active multiple sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2015
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary) ; Glatiramer acetate; Interferon beta
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 16 Oct 2015 New trial record